Android app on Google Play

Cantor Fitzgerald Starts Cleveland BioLabs (CBLI) at Buy

March 20, 2013 4:24 PM EDT Send to a Friend
Get Alerts CBLI Hot Sheet
Price: $0.47 +9.30%

Rating Summary:
    4 Buy, 2 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 23 | New: 21
Trade CBLI Now!
Join SI Premium – FREE
Cantor Fitzgerald initiated coverage on Cleveland BioLabs (NASDAQ: CBLI) with a Buy rating and a price target of $4.00.

"The shares are laboring under several overhangs, which we believe will recede over time. As these dissipate, we believe the shares could trade to a valuation that approaches biodefense peers, leaving upside from the pipeline," said analyst Mara Goldstein.

For an analyst ratings summary and ratings history on Cleveland BioLabs click here. For more ratings news on Cleveland BioLabs click here.

Shares of Cleveland BioLabs closed at $1.76 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, New Coverage

Related Entities

Cantor Fitzgerald

Add Your Comment